Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coenraad F Slabber

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Metabolism|April 25, 2025
Starvation induces metabolic hepatocyte reprogrammingCoenraad F Slabber, Jan S Tchorz
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 5, 2003
Guidelines for CPD accreditation of the South African Society of Medical OncologyRaymond P Abratt, Richard W Eek, Richard Eele, et al.
Gastrointestinal Cancer Research : GCR|April 6, 2011
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology GroupJoanne F Rossman, Carla I Falkson, Ronghui Xu, et al.
Iscience|October 14, 2021
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosisAbbie E Fearon, Coenraad F Slabber, Andrii Kuklin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Metabolism|April 25, 2025
Starvation induces metabolic hepatocyte reprogrammingCoenraad F Slabber, Jan S Tchorz
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 5, 2003
Guidelines for CPD accreditation of the South African Society of Medical OncologyRaymond P Abratt, Richard W Eek, Richard Eele, et al.
Gastrointestinal Cancer Research : GCR|April 6, 2011
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology GroupJoanne F Rossman, Carla I Falkson, Ronghui Xu, et al.
Iscience|October 14, 2021
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosisAbbie E Fearon, Coenraad F Slabber, Andrii Kuklin, et al.
Pageof 1